Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | TLX | VRDN | ||
| Company | Dicerna Pharmaceutic | Telix Pharmaceuticals Limited ADR | Viridian Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 9.18 | 27.86 | ||
| High | 38.24 | 9.31 | 28.19 | ||
| Low | 38.21 | 8.93 | 27.29 | ||
| Latest | 38.22 | 9.21 | 27.40 | ||
| Change | +0.22 | +0.24 | -0.80 | ||
| % Change | +0.58% | +2.68% | -2.84% | ||
| Volume | 5,568,900 | 198,723 | 829,020 | ||
| 20-Day Average Volume | 3,647,665 | 286,973 | 1,302,077 | ||
| Previous Close | 38.00 | 8.97 | 28.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 8.06 | 28.55 | ||
| 20-Day Raw Stochastic | 90.72% | 95.79% | 38.65% | ||
| 20-Day Relative Strength | 80.40 | 64.04 | 45.50 | ||
| Weighted Alpha | +35.17 | -38.31 | +85.79 | ||
| Today's Opinion | 88% Buy | 8% Sell | 8% Sell | ||
| Previous Opinion | 72% Buy | 8% Sell | 8% Sell | ||
| Last Month's Opinion | 24% Buy | 64% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | +5.03% since 03/20/26 | +3.85% since 03/20/26 | ||
| Low | 37.81 on 12/21/21 | 8.62 on 03/24/26 | 26.27 on 03/24/26 | ||
| High | 38.24 on 12/27/21 | 9.30 on 03/27/26 | 28.59 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +26.76% since 02/27/26 | -4.63% since 02/27/26 | ||
| Low | 37.78 on 12/10/21 | 6.69 on 03/03/26 | 26.27 on 03/24/26 | ||
| High | 38.26 on 12/03/21 | 9.30 on 03/27/26 | 30.79 on 03/05/26 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +14.45% since 12/26/25 | -12.11% since 12/26/25 | ||
| Low | 19.06 on 10/06/21 | 6.28 on 02/17/26 | 26.27 on 03/24/26 | ||
| High | 38.26 on 12/03/21 | 9.30 on 03/27/26 | 34.29 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -7.92% since 09/26/25 | +38.78% since 09/26/25 | ||
| Low | 19.06 on 10/06/21 | 6.28 on 02/17/26 | 19.93 on 09/29/25 | ||
| High | 40.14 on 07/20/21 | 11.29 on 10/15/25 | 34.29 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,039,852 | 2,882,238 | ||
| Shares Outstanding, K | 78,129 | 338,891 | 102,207 | ||
| Annual Sales | 164,310,000 | 803,790,000 | 70,850,000 | ||
| Annual Net Income | -112,750,000 | -7,130,000 | -342,600,000 | ||
| Last Quarter Sales | 62,950,000 | N/A | 130,000 | ||
| Last Quarter Net Income | -17,070,000 | N/A | -120,360,000 | ||
| 60-Month Beta | 0.80 | 0.52 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | N/A | -1.08 on 02/26/26 | ||
| Latest Earnings Date | 02/24/22 | 05/21/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||